Amantadine hydrochloride extended release - Adamas Pharmaceuticals
Alternative Names: ALLAY-LID I; ALLAY-LID II; Amantadine HCl ER; Amantadine HCl Extended Release Tablets - RVL Pharmaceuticals; OS-320; Osmolex ERLatest Information Update: 18 Mar 2024
At a glance
- Originator Osmotica Pharmaceutical
- Developer RVL Pharmaceuticals
- Class Adamantanes; Antiparkinsonians; Antivirals; Organic bridged compounds; Small molecules
- Mechanism of Action Dopamine receptor agonists; NMDA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Drug-induced dyskinesia; Parkinson's disease